期刊文献+

非小细胞肺癌术后辅助化疗的再认识

New Recognize for Adjuvant Chemotherapy in Non-small Cell Lung Cancer
原文传递
导出
摘要 非小细胞肺癌(NSCLC)术后辅助化疗的地位虽然较为确切,但疗效并不显著,尤其在早期患者中获益不明显,远期结果有待于进一步观察。同时该治疗也受到靶向药物治疗的严峻挑战。在生物标志物的指导下个体化化疗以及与靶向药物结合的联合化疗将成为发展的趋势。
作者 毛伟敏
机构地区 浙江省肿瘤医院
出处 《肿瘤学杂志》 CAS 2009年第8期689-692,共4页 Journal of Chinese Oncology
  • 相关文献

参考文献21

  • 1Mountain CF. Revisions in the International System for Staging Lung Cancer[J]. Chest, 1997, 111(6):1710-1717.
  • 2Chemotherapy in non-small cell lung cancer, A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group[J]. BMJ, 1995, 311(7010):899-909.
  • 3Stewart LA, Burdett S, Tierney JF, et al. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC), A meta-analysis using individual patient data (IPD) from randomized clinical trials(RCT)[C]. J Clin Oncol,2007,25:397s.
  • 4Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation:A pooled analysis by the LACE Collaborative Group [J]. J Clin Oncol, 2008, 26 (21):3552- 3559.
  • 5Felip E, Massuti G, Alonso G, et al. Surgery(S) alone, preoperative (prep) paclitaxel/carboplatin (PC) chemotherapy followed by S, or S followed by adjuvant (adj) PC chemotherapy in early-stage non-small cell lung cancer (NSCLC): Results of the NATCH muhicenter, randomized phase Ⅲ trial[C]. J Clin Oncol, 27:15s, 2009(suppl; abstr 7500).
  • 6Douillard JY, Rosell R, De Lena M, et al. Adjuvant inorelbine plus cisplatin versus observation in patients with completely resected stage Ⅰb-Ⅲ a non-small-cell lung cancer (adjuvant navelbine international trialist association [ANITA]): a randomised controlled trial [J]. Lancet Oncol, 2006, 7(9):719-727.
  • 7Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage Ⅰ B non-small-cell lung cancer: CALGB 9633 with Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups[J]. J Clin Oncol, 2008, 6(31):5043-5051.
  • 8Winton T,Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[J]. N Engl J Med, 2005, 352(25):2589-2597.
  • 9Vincent MD, Butts C, Seymour L, et al. Updated survival analysis of JBR.10: A randomized phase Ⅲ trial of vinorelbine/cisplatin versus observation in completely resected stage Ⅰ B and Ⅱ non-small cell lung cancer (NSCLC)[C]. J Clin Oncol, 27:15s, 2009(suppl; abstr7501).
  • 10Le Chevalier T, Dunant A, Arriagada R, et al. Long-term results of the International Adjuvant Lung Cancer Trial (IALT) evaluating adjuvant cisplatin based chemotherapy in resected non-small cell lung cancer (NSCLC)[C]. J Clin Oncol, 26:2008(May 20 suppl; abstr 7507).

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部